BCRX BioCryst Pharmaceuticals, Inc.
Healthcare$8.29-0.96%ClosedMarket Cap: $1.74B
As of 2026-05-25
Analyst Consensus
Consensus
Buy
Target (Consensus)
$16.86
Target (Median)
$15.00
Target Range
$8.00 - $25.00
Upside from current price: 103.4%
Rating Distribution
3 Strong Buy7 Buy0 Hold0 Sell0 Strong Sell
Recent Analyst Ratings
| Date | Firm | Action | Rating | Previous |
|---|---|---|---|---|
| 2026-05-07 | Wedbush | maintain | Outperform | Outperform |
| 2026-05-07 | Citizens | maintain | Market Outperform | Market Outperform |
| 2026-05-06 | Needham | maintain | Buy | Buy |
| 2026-01-30 | RBC Capital | maintain | Outperform | Outperform |
| 2025-12-15 | HC Wainwright & Co. | maintain | Buy | Buy |
| 2025-11-05 | Citizens | maintain | Market Outperform | Market Outperform |
| 2025-11-04 | Needham | maintain | Buy | Buy |
| 2025-11-04 | Barclays | maintain | Equal Weight | Equal Weight |
| 2025-10-15 | JMP Securities | maintain | Market Outperform | Market Outperform |
| 2025-10-15 | Cantor Fitzgerald | maintain | Overweight | Overweight |
Forward Estimates
| Period | EPS Est. | Revenue Est. | # Analysts |
|---|---|---|---|
| Fri Dec 31 | $0.31 | $727.2M | 4 |
| Sun Dec 31 | $0.43 | $864.0M | 6 |
| Mon Dec 31 | $0.91 | $1.05B | 4 |
| Tue Dec 31 | $1.43 | $1.25B | 2 |